Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mustea

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Zentralblatt Fur Gynakologie|September 10, 2003
["IMO"--intraoperative mapping of ovarian cancer]J Sehouli, D Könsgen, A Mustea, et al.
British Journal of Anaesthesia|October 11, 2012
Implementation of the quality management system improves postoperative pain treatment: a prospective pre-/post-interventional questionnaire studyT I Usichenko, I Röttenbacher, T Kohlmann, et al.
Geburtshilfe Und Frauenheilkunde|June 2, 2015
Should Fallopian Tubes Be Removed During Hysterectomy Procedures? - A Statement by AGO OvarM Pölcher, S Hauptmann, C Fotopoulou, et al.
Cytokine|March 11, 2008
Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancerA Mustea, C Pirvulescu, D Könsgen, et al.
Geburtshilfe Und Frauenheilkunde|November 12, 2015
Statement by the Kommission Ovar of the AGO: The New FIGO and WHO Classifications of Ovarian, Fallopian Tube and Primary Peritoneal CancerI Meinhold-Heerlein, C Fotopoulou, P Harter, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 3, 2006
An estrogen receptor alpha-dependent regulation of estrogen receptor-related receptor alpha in the proliferation of endometrial carcinoma cellsP-M Sun, M Gao, L-H Wei, et al.
Geburtshilfe Und Frauenheilkunde|April 29, 2014
Statement by the Kommission OVAR of the AGO Study Group on the Use of HIPEC (Hyperthermic Intraperitoneal Chemotherapy) to Treat Primary and Recurrent Ovarian CancerP Harter, S Mahner, F Hilpert, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 1, 2007
Online tumor conference in the clinical management of gynecological cancer: experience from a pilot study in GermanyR Chekerov, C Denkert, D Boehmer, et al.
Archives of Gynecology and Obstetrics|October 27, 2021
Impact of COVID-19 on gynaecological patient care: results of patient's survey with 327 patientsF Recker, S Dohmen, E K Egger, et al.
Journal of Cancer Research and Clinical Oncology|February 27, 2023
Ovarian cancer prevention by opportunistic salpingectomy is a new de facto standard in GermanyI B Runnebaum, A Kather, J Vorwergk, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Zentralblatt Fur Gynakologie|September 10, 2003
["IMO"--intraoperative mapping of ovarian cancer]J Sehouli, D Könsgen, A Mustea, et al.
British Journal of Anaesthesia|October 11, 2012
Implementation of the quality management system improves postoperative pain treatment: a prospective pre-/post-interventional questionnaire studyT I Usichenko, I Röttenbacher, T Kohlmann, et al.
Geburtshilfe Und Frauenheilkunde|June 2, 2015
Should Fallopian Tubes Be Removed During Hysterectomy Procedures? - A Statement by AGO OvarM Pölcher, S Hauptmann, C Fotopoulou, et al.
Cytokine|March 11, 2008
Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancerA Mustea, C Pirvulescu, D Könsgen, et al.
Geburtshilfe Und Frauenheilkunde|November 12, 2015
Statement by the Kommission Ovar of the AGO: The New FIGO and WHO Classifications of Ovarian, Fallopian Tube and Primary Peritoneal CancerI Meinhold-Heerlein, C Fotopoulou, P Harter, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 3, 2006
An estrogen receptor alpha-dependent regulation of estrogen receptor-related receptor alpha in the proliferation of endometrial carcinoma cellsP-M Sun, M Gao, L-H Wei, et al.
Geburtshilfe Und Frauenheilkunde|April 29, 2014
Statement by the Kommission OVAR of the AGO Study Group on the Use of HIPEC (Hyperthermic Intraperitoneal Chemotherapy) to Treat Primary and Recurrent Ovarian CancerP Harter, S Mahner, F Hilpert, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 1, 2007
Online tumor conference in the clinical management of gynecological cancer: experience from a pilot study in GermanyR Chekerov, C Denkert, D Boehmer, et al.
Archives of Gynecology and Obstetrics|October 27, 2021
Impact of COVID-19 on gynaecological patient care: results of patient's survey with 327 patientsF Recker, S Dohmen, E K Egger, et al.
Journal of Cancer Research and Clinical Oncology|February 27, 2023
Ovarian cancer prevention by opportunistic salpingectomy is a new de facto standard in GermanyI B Runnebaum, A Kather, J Vorwergk, et al.
Pageof 3